Li, Maohua
Zhao, Rongqing
Chen, Jianxin
Tian, Wenzhi
Xia, Chenxi
Liu, Xudong
Li, Yingzi
Li, Song
Sun, Hunter
Shen, Tong
Ren, Wenlin
Sun, Le
Article History
Received: 24 July 2020
Accepted: 26 February 2021
First Online: 11 March 2021
Change Date: 28 March 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41598-022-09081-4
Competing interests
: Maohua Li, Wenlin Ren and Le Sun are affiliated with AbMax BioPharmaceuticals, Jianxin Chen is affiliated with ZhenGe Biotechnology, and Wenzhi Tian and Song Li are affiliated with ImmuneOnco Biopharma. They declare stakes in the data. Patent of De-ADCC is pending. The rest of the authors declare no conflict of interest.